The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity
Open Access
- 1 July 2007
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 48 (7), 1637-1646
- https://doi.org/10.1194/jlr.d600045-jlr200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: Relevance to diabetesAtherosclerosis, 2006
- P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: The Atherosclerosis Risk In Communities StudyAtherosclerosis, 2006
- Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-IJournal of Lipid Research, 2006
- The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease statusJournal of Lipid Research, 2005
- Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiesJournal of Lipid Research, 2005
- Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemiaJournal of Lipid Research, 2005
- The 'evolvability' of promiscuous protein functionsNature Genetics, 2004
- Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?Free Radical Biology & Medicine, 2004
- Human Serum Paraoxonase 1 Decreases Macrophage Cholesterol BiosynthesisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Two Alleles of the Human Paraoxonase Gene Produce Different Amounts of mRNAArteriosclerosis, Thrombosis, and Vascular Biology, 1997